Clinical Trials Browser

Recruiting × Hemangioendothelioma, Epithelioid × Clear all

Sarcoma, Hemangioendothelioma, Epithelioid

NCT07104331 2026-03-03

SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma

Phase 2 Recruiting

41 enrolled

Hemangioendothelioma, Epithelioid

NCT03967834 2026-02-10

MIRAS

Phase NA Recruiting

400 enrolled

Sarcoma

Sarcoma, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Hemangioendothelioma, Epithelioid, Perivascular Epithelioid Cell Neoplasms, Desmoplastic Small Round Cell Tumor

NCT06239272 2026-01-26

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Phase 1/2 Recruiting

139 enrolled

Plasma cellSarcoma

Histiocytoma, Angiomatoid Fibrous, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Glomus Tumor, Granuloma, Plasma Cell, Hemangiosarcoma, Liposarcoma, Myoepithelioma, Sarcoma, Osteosarcoma, Disorders of Sex Development, Granular Cell Tumor, Neoplasms, Adipose Tissue, Liposarcoma, Myxoid, Dermatofibrosarcoma, Sarcoma, Clear Cell, Smooth Muscle Tumor, Nerve Sheath Neoplasms, Neurofibrosarcoma, Hemangioendothelioma, Epithelioid, Vascular Neoplasms, Solitary Fibrous Tumors

NCT06452160 2024-08-09

A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors

Phase 1 Recruiting

103 enrolled

Other solid neoplasmThoracic

Mesothelioma, Hemangioendothelioma, Epithelioid

Clinical Trials

EHE

SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma

MIRAS

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors